InTune

What we do

Intune quantifies and improves one of the most expensive decisions before recruitment begins.

A decision layer for sponsors and CROs before execution

Most timeline risk gets locked in at site selection. Intune provides an independent validation step that challenges self-reported feasibility assumptions and prioritizes sites by likelihood to activate and recruit for your specific protocol.

Explainable site selection decisions

We deliver ranked shortlists with site-level risk flags and the reasoning behind each recommendation. Teams can align faster, act with confidence, and avoid committing to sites that look good on paper but do not deliver.

Activation and enrollment risk, made actionable

Validation highlights the practical factors that typically slow studies down, then translates them into next actions. The output is built to drive decisions, not just produce scores.

Works alongside sponsors and CROs

Intune is not a replacement for CROs. We strengthen feasibility and startup decision-making by helping teams focus early effort on higher-probability sites and reduce downstream rescue workload.

What you get

Clinical site selection • Study startup • Site activation • Trial rescue • Medical devices • Diagnostics • Therapeutics • Global studies

Decision Intelligence Before Recruitment

Most trial delays begin before recruitment starts. Intune helps sponsors evaluate and prioritize the right clinical sites early, reducing startup risk and avoiding costly enrollment delays later.

Scientific Site Selection and Predictive Matching

Intune combines AI, historical performance data, operational readiness, and study-specific criteria to identify sites most likely to activate quickly and meet enrollment targets.

Faster Startup, Lower Enrollment Risk

By focusing outreach on the highest-potential sites first, Intune helps reduce startup delays, improve enrollment performance, and minimize costly trial underperformance.

Global Site Intelligence

Intune supports sponsors across North America, Europe, Asia, and beyond with data-driven site recommendations tailored to regional regulations, patient access, and study needs.

How site selection works

Define your study goals and constraints

Share protocol requirements, geographic priorities, enrollment goals, timelines, and operational constraints. For delayed studies, we will evaluate existing site performance and enrollment challenges

Validate protocol-to-site fit

We assess site fit against protocol requirements and operational realities using performance, readiness, and enrollment signals to identify where traditional feasibility may overestimate outcomes.

Receive an explainable ranked shortlist

Get a scored and prioritized list of sites with risk flags, enrollment considerations, and explainable rationale to support faster internal alignment and decision-making.

Support activation and study rescue (optional add-on)

Use the scored shortlist to focus outreach, feasibility, startup, activation planning,  or rescue efforts for delayed studies. Optional execution support can be scoped to accelerate activation and improve enrollment performance.

Start an Evaluation

Why sponsors and CROs choose Intune

Independent and explainable scoring and selection logic

Make decisions you can defend internally.
Recommendations include the reasoning and key risk factors behind prioritization. Teams get transparency, which makes alignment and action faster.

Realistic activation and enrollment forecasting

Replace feasibility optimism with operational realism.
Traditional feasibility often relies on self-reported surveys and prior relationship bias. Intune uses operational signals, protocol-specific parameters, and comparative intelligence to help teams set more realistic expectations for activation speed and enrollment performance under current conditions.

Complements CRO workflows

An independent layer that strengthens feasibility.
Intune supports CRO and sponsor teams by validating assumptions early, prioritizing higher-probability sites, and reducing the need for costly delays and mid-study corrections.

Scoped for multi-region studies

Validation that accounts for regional realities.
We scope by protocol and geography, accounting for startup constraints and practical operational considerations across regions.

Reduce delays and mid-study corrections

Avoid “more of everything” rescue motions.
Early validation and prioritization helps teams avoid costly false starts, delayed activation, unnecessary site additions, and repeated mid-study corrections.

See What Our Users Are Saying

Intune Bio has completely transformed our approach to clinical trial site selection. Within days, we connected with high-quality research sites that matched our study criteria perfectly. The platform’s streamlined process saved us months of manual searching!

MediCare Company

Sarah M., Clinical Operations Manager

We used Intune Bio to find trial sites for our Phase II study, and the results were outstanding. The platform helped us secure qualified sites faster and at a fraction of the cost compared to traditional methods. Intune Bio is now a core part of our clinical trial strategy.

MedicalCoup

David R., VP of Clinical Development

The real-time messaging and proposal management tools on Intune Bio have made site collaboration effortless. We quickly compared proposals, aligned on timelines, and launched our trial without delays. A game-changer for trial efficiency!

FarmaClever

Jessica L., Director of Research

Finding international trial sites used to be a challenge, but Intune Bio made it simple. We connected with top-tier facilities across Europe and Asia, ensuring a diverse patient population for our study. The platform’s global network is invaluable.

BioTech

Michael T., Regulatory Affairs Lead

Quality and compliance are top priorities for us, and Intune Bio delivered. The platform only connects us with vetted, experienced trial sites that meet regulatory requirements. This peace of mind is invaluable in today’s complex clinical landscape.

FarmService Group

Emily S., Head of Clinical Trials

As a growing biotech company, we needed a scalable solution to manage trial site selection efficiently. Intune Bio provided an intuitive platform that grows with us, ensuring we always find the right partners for our studies. Highly recommended!

ClinicTrials Group

Mark D., CEO

Frequently Asked Questions

What does Intune do?

Intune is a decision intelligence platform for sponsors and CROs to validate and prioritize clinical site selection decisions using AI-assisted analysis, standardized scoring, and comparisons across large datasets of similar sites and studies. We provide scored shortlists, site-level risk flags, and explainable rationale to support faster activation and stronger enrollment outcomes.

How is Intune different from traditional feasibility?

Traditional feasibility often relies on surveys, legacy relationships, and self-reported site data. Intune adds an independent validation methodology focused on activation and enrollment likelihood under current real-world conditions, with explainable reasoning.

Does Intune replace CROs?

No. Intune is designed to complement sponsors and CROs by strengthening site selection and startup decision-making. We help teams focus earlier on higher-probability sites and reduce downstream corrections.

What types of studies does Intune support?

We scope based on protocol needs. Common coverage includes therapeutics across Phase I–IV trials, vaccines, diagnostics, and medical devices, including multi-region programs.

How does Intune identify best-fit sites?

Intune evaluates protocol-to-site fit using AI-assisted analysis, operational readiness signals, startup constraints, and comparative intelligence across similar sites and studies. Sites are then prioritized using standardized scoring, with documented rationale and risk factors behind each recommendation.

Can Intune help accelerate study startup?

Yes. By prioritizing stronger-fit sites earlier and reducing time spent on low-probability outreach, teams can reduce avoidable activation delays and improve enrollment predictability.

Do clinical sites need to join a platform?

Not necessarily. Intune can evaluate and score proposed sites using protocol inputs, operational signals, and comparative site intelligence.

Does Intune support global studies?

Yes. We scope by protocol and geography and account for regional considerations and startup constraints across multi-region studies.

Why focus on site selection?

Site selection decisions shape activation speed, enrollment performance, and overall study timelines, and can become one of the most expensive sources of delay in a clinical trial. Intune helps sponsors and CROs independently validate assumptions early so teams can avoid costly false starts, mid-study corrections, and downstream rescue efforts.

What data does Intune use for site evaluation?

We use non-confidential study inputs together with operational signals, startup readiness indicators, and comparative intelligence across similar sites and studies to support prioritization. We do not request or store patient-level data.

Can Intune help rescue delayed studies?

Yes. We support rescue by triaging which sites are recoverable, identifying key risks, and prioritizing actions and alternatives that can realistically recover timeline.

Who benefits most from Intune?

Sponsor and CRO teams that need faster activation, more predictable enrollment, and a defensible rationale for site selection decisions, especially when timelines are tight or confidence in the shortlist is low.

Site selection intelligence for faster activation and stronger enrollment

Pre-study (Decision layer)

In-study (Rescue triage)